Cargando…

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure

BACKGROUND: The Z0011 trial initiated a paradigm shift in the axillary treatment of breast cancer patients with a positive sentinel lymph node biopsy (SLNB), disregarding patients with a positive ultrasound-guided lymph node biopsy (UGLNB). We examined whether relevant differences exist between thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verheuvel, Nicole C., Voogd, Adri C., Tjan-Heijnen, Vivianne C. G., Siesling, S., Roumen, Rudi M. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602026/ https://www.ncbi.nlm.nih.gov/pubmed/28656490 http://dx.doi.org/10.1007/s10549-017-4342-1

Ejemplares similares

What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool
por: van den Hoven, Ingrid, et al.
Publicado: (2019)

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
por: Truin, Wilfred, et al.
Publicado: (2017)

Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
por: Roy, P., et al.
Publicado: (2018)

Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline E. F., et al.
Publicado: (2023)

Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
por: Skarping, Ida, et al.
Publicado: (2021)

Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023)

Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?
por: Evans, Andrew, et al.
Publicado: (2013)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018)

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
por: Zetterlund, Linda Holmstrand, et al.
Publicado: (2017)

Sentinel lymph node biopsy of the internal mammary chain in breast cancer
por: Postma, E. L., et al.
Publicado: (2012)

Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients
por: Pislar, Nina, et al.
Publicado: (2023)

Imprint Cytology Predicts Axillary Node Status in Sentinel Lymph Node Biopsy
por: Bell, Zarina, et al.
Publicado: (2010)

Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node
por: Shojaee, Leyla, et al.
Publicado: (2020)

Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?
por: You, Ji Young, et al.
Publicado: (2023)

Prediction of negative axillary node clearance by sentinel node-positive to total node ratio: a retrospective cohort study
por: Rosen, Jemima, et al.
Publicado: (2023)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Current management of patients with melanoma who are found to be sentinel node‐positive
por: Nijhuis, Amanda A. G., et al.
Publicado: (2019)

Diagnostic value of preoperative axillary lymph node ultrasound assessment in patients with breast cancer qualified for sentinel lymph node biopsy
por: Nowikiewicz, Tomasz, et al.
Publicado: (2015)

Frequency and diagnostic outcome of bilateral recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy
por: Kil, Won Ho, et al.
Publicado: (2014)

Axillary management still needed for patients with sentinel node micrometastases
por: Cong, Bin-Bin, et al.
Publicado: (2019)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer
por: Rukanskienė, Dalia, et al.
Publicado: (2020)

Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer
por: Dixon, J. Michael, et al.
Publicado: (2020)

Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
por: van Haaren, Elisabeth R. M., et al.
Publicado: (2023)

Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis
por: Ram, Rachna, et al.
Publicado: (2014)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer
por: Qiu, Ya, et al.
Publicado: (2022)

Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de‐escalating approach
por: van Steenhoven, Julia E. C., et al.
Publicado: (2022)

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
por: de Boniface, Jana, et al.
Publicado: (2017)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
por: Choi, Hee Jun, et al.
Publicado: (2018)

Identification of Risk Factors Associated with Axillary Lymph Node Metastasis for Sentinel Lymph Node-Positive Breast Cancer Patients
por: He, Zhen, et al.
Publicado: (2020)

Will early detection of non-axillary sentinel nodes affect treatment decisions?
por: Wärnberg, F, et al.
Publicado: (2002)

Which Patients Need an Axillary Clearance after Sentinel Node Biopsy?
por: Pazaiti, Anastasia, et al.
Publicado: (2011)

Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
por: Bear, HD
Publicado: (2005)

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
por: Sarri, Almir José, et al.
Publicado: (2017)

Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Kristen, P, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_7o1o6i909a7g9okahtu7kvdmp0